Dr. Agarwal's Eye Hospital Limited (BOM:526783)

BOM:526783 Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	701	546.5	463.6	369.2	241
Depreciation & Amortization	455.8	393.9	265.2	199.2	199.6
Other Amortization	0.6	0.6	0.9	2.6	4.3
Loss (Gain) From Sale of Assets	-	1.6	2.3	-0.3	-2.2
Loss (Gain) From Sale of Investments	-27.7	-8.8	-	-	-
Provision & Write-off of Bad Debts	13.3	3.9	8.6	8	13.2
Other Operating Activities	247.1	68	57.3	68.1	49.7
Change in Accounts Receivable	-60.7	-14.6	-37.1	-19.8	-12.2
Change in Inventory	-7	-36.5	-37.5	-2.7	-5.1
Change in Accounts Payable	-	-	68.6	10.3	83.4
Change in Other Net Operating Assets	129	-19	105.8	61.6	-4.9
Operating Cash Flow	1,451	935.6	897.7	696.2	566.8
Operating Cash Flow Growth	55.13%	4.22%	28.94%	22.83%	67.33%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-983.9	-1,029	-713.2	-703.4	-467.3
Sale of Property, Plant & Equipment	5.5	4.1	10	0.7	3.2
Cash Acquisitions	-23	-184.8	-5	-	-
Investment in Securities	-736.6	-117.5	-	-	-
Other Investing Activities	2.7	-1	7.8	-3.4	1.3
Investing Cash Flow	-1,735	-1,328	-700.4	-706.1	-462.8

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	-	-	-	30
Long-Term Debt Issued	-	561.8	150	209.4	257.5
Total Debt Issued	-	561.8	150	209.4	287.5
Short-Term Debt Repaid	-	-	-	-	-38.7
Long-Term Debt Repaid	-404.9	-340.7	-264.2	-174.9	-268.8
Total Debt Repaid	-404.9	-340.7	-264.2	-174.9	-307.5
Net Debt Issued (Repaid)	-404.9	221.1	-114.2	34.5	-20
Issuance of Common Stock	696.6	-	-	-	-
Common Dividends Paid	-30.9	-23.5	-25.8	-14.1	-0.2
Other Financing Activities	-13	-31.8	-2.3	-17.8	-17.9
Financing Cash Flow	247.8	165.8	-142.3	2.6	-38.1

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	-36.1	-226.4	55	-7.3	65.9

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	467.5	-93	184.5	-7.2	99.5
Free Cash Flow Growth	-	-	-	-	-56.15%
Free Cash Flow Margin	9.93%	-2.34%	5.78%	-0.27%	4.95%
Free Cash Flow Per Share	98.05	-19.79	39.26	-1.53	21.17
Levered Free Cash Flow	171.9	-246.59	104.08	-171.21	12.45
Unlevered Free Cash Flow	245.84	-169.34	148.45	-128.71	50.7

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	13	31.8	2.3	17.8	17.9
Cash Income Tax Paid	90.4	201.3	136.1	115.2	89.3
Change in Working Capital	61.3	-70.1	99.8	49.4	61.2

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error